Jan 19 (Reuters) - Neurovive Pharmaceutical Ab NVP.ST :
* Neurovive presents positive preclinical data in hepatocellular cancer at HCC summit
* Says that an abstract with novel preclinical cancer data related to the company's sanglifehrin-based compounds has been accepted for presentation at the scientific conference EASL HCC Summit Source text for Eikon: ID:nWkrar0953 Further company coverage: NVP.ST